According to Amneal Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.756687. At the end of 2023 the company had a P/S ratio of 0.7774.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.7774 | 184.66% |
2022 | 0.2731 | -20.09% |
2021 | 0.3417 | 0.93% |
2020 | 0.3386 | -61.81% |
2019 | 0.8867 | -63.51% |
2018 | 2.43 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | 1.02 | 34.41% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | 92.5 | 12,124.16% | ๐บ๐ธ USA |